Free Primary Care CME

Meet a 52-year-old woman with type 2 diabetes and hypertension whose recent laboratory results reveal a decline in kidney function. How would you manage this patient? In this 15-minute activity, read about next steps in the management of advanced kidney disease.

Pri-Med’s CME/CE courses are designed with primary care doctors in mind. We cover topics that reflect a typical day in primary care practice, and our CME/CE courses offer AMA PRA Category 1 Credits™ to help you fulfill your state and board requirements. Choose from hundreds of online CME/CE courses across 40 therapeutic areas and learn key insights from expert clinician-educators that you can apply immediately to your practice.

Upon completion of this activity, learners will be able to:

• Implement routine OSA screening for patients with obesity and other OSA risk factors.
• Identify tools that can aid in screening patients for OSA.
• Initiate diagnostic workups for patients with suspected OSA.
• Evaluate results from OSA diagnostic studies.
• Implement multidisciplinary approaches to formulate tailored management strategies for OSA that account for patient preferences and new therapeutic options.

NTM-LD is a rare but serious condition, most commonly caused by Mycobacterium avium complex (MAC), and disproportionately affects patients with underlying lung diseases such as bronchiectasis, chronic obstructive pulmonary disease (COPD), and asthma—leading to delayed diagnosis, progressive lung damage, and diminished quality of life.

Unlike traditional lectures, this Dialogues program brings attendees into the conversation. Through real-time audience interaction, multidisciplinary expert insights, and real-world patient cases, you’ll explore the complexities of NTM-LD alongside leading specialists in an engaging, studio-quality format. This expert-led activity will include discussion and audience-driven dialogue as participants will examine current and emerging treatment strategies, including approaches for recurrent infection, and explore how evidence-based therapeutic decision-making can optimize clinical outcomes and improve patient quality of life.

This activity is derived from a Live Symposium at ATS 2026, originally held on May 19, 2026.

In this online, self-learning activity:

Since the discovery and development of vaccines, historical leaps have been made on public health, contributing to longevity and reduced burden of infectious diseases. Ever since the World Health Organization (WHO) launched the Expanded Program on Immunization in 1974, 154 million deaths from smallpox, tuberculosis, measles, and other infectious diseases have been avoided, especially in children under the age of 5. Between 2000 to 2019, immunization has expanded its reach in infectious targets and helped prevent about 37 million deaths from 10 vaccine-preventable deaths. Despite vaccines being a cost-effective method for reducing severe consequences of infection and high-cost treatments, vaccination rates have been decreasing amongst the general public, failing to meet national and global goals. The cause is multi-factorial and complex, requiring understanding in human behavior, internal biases, and external circumstances to explore how an individual navigates the process of deciding whether or not to be vaccinated.

In this MedX activity, Michael Blaha, MD, explores the evolving landscape of low-density lipoprotein cholesterol (LDL-C) management in patients with atherosclerotic cardiovascular disease (ASCVD), with a focus on the current role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors and how emerging novel PCSK9 inhibitor formulations may be integrated into clinical practice as they become available.

UTI at the Point of Care: Diagnostic and Treatment Decisions That Matter is a blended-learning curriculum designed for primary care clinicians, urologists, gynecologists, and other members of the health care team who treat patients with uncomplicated urinary tract infections (uUTIs). Although uUTIs are among the most common infections prompting antibiotic use, nearly half of prescriptions remain inappropriate or non–guideline-concordant. Through interactive, case-based discussion with expert faculty and peers, participants will practice distinguishing uUTI from asymptomatic bacteriuria, complicated UTI, and pyelonephritis. Participants will review guideline-concordant regimens, including novel agents, informed by local resistance patterns and antimicrobial stewardship principles. Participants will also apply risk-based stratification to guide urine culture use and therapy selection. Finally, participants will develop patient-centered strategies that reduce the burden of uUTIs on patients and the health care system.

Pri-Med is committed to supporting you in meeting the Drug Enforcement Administration (DEA) CME training requirements under the MATE Act. The free CME courses offered here focus on opioid and substance use disorders and can be combined in any way to complete the eight-hour training mandate. 

Bronchiectasis is a complex and increasingly prevalent condition often overlooked in clinical practice, with frequent overlap with other respiratory diseases such as COPD and asthma. Persistent airway inflammation, chronic infection, and mucociliary dysfunction drive disease progression, leading to significant morbidity and healthcare burden. As the clinical burden of bronchiectasis becomes increasingly recognized, there is an urgent need to better understand the underlying mechanisms of neutrophilic inflammation, alongside efforts to improve early diagnosis and explore current and emerging treatment options that target this vicious cycle.

In this activity, a panel of leading pulmonologists tackle the evolving challenges and emerging opportunities in bronchiectasis management. From diagnostic workup to airway clearance and exacerbation control, the discussion will blend expert insight with real-world clinical scenarios and patient perspectives.
Endocrinologists, endocrinology NPs and PAs, and the broader care team are positioned to close it. This training program, modeled on the CDC Training of Trainers approach, equips endocrinology-led teams to build CKM risk into everyday T2D decision-making: selecting and sequencing GLP-1-based therapies according to a patient’s cardiovascular, renal, and metabolic profile, not glycemic control alone. The content also addresses related benefits emerging in this drug class, including MASH and OSA, within the broader CKM framework.Designed to update clinicians on data presented at the American Society of Retina Specialists 43rd Annual Meeting held in Long Beach, CA, from July 30 to August 2, 2025
Expert thought leaders provide insights to help clinicians apply these findings to their management of patients with nAMD, DME, and RVO when using newer therapies that support longer treatment intervals.

Understanding pharmacologic management of disease is a crucial aspect of providing high-quality medical care. Our courses offer practical guidance on pharmacologic management of disease processes to avoid potentially negative interactions between substances. Choose from a variety of free pharmacology CME/CE courses to improve care for your patients. Earn credits at no cost today.

This educational initiative focuses on empowering HCPs to optimize individualized care for patients with Type 2 diabetes (T2D). The interactive Real Answers to Real Questions format will integrate extensive peer-to-peer discussion into didactic presentation elements and provide clinicians with the opportunity to examine the latest clinical data and scientific advancements related to once-weekly basal insulins poised to enter the treatment armamentarium for this disease. By tackling real-world, practical questions that clinicians face every day, the activity will enhance HCPs’ confidence in the application of novel weekly basal insulins in routine practice when they become available, ultimately advancing equitable, patient-centered outcomes in T2D care.

This accredited activity reviews advancements in lung transplant surgery, with a focus on robotic lung transplant and ex vivo lung perfusion.

Advancing the Pediatric to Adult Continuum in IBS-C: Evidence-Based Treatment and Transitions of Care is a continuing medical education (CME) activity designed for US-based pediatric and adult gastroenterologists, nurse practitioners, physician assistants, GI nursing professionals, transition coordinators, and behavioral health specialists involved in the care of patients with IBS-C. This activity focuses on applying evidence-based approaches to the selection, initiation, dosing, and monitoring of newly approved and emerging therapeutic agents in pediatric patients aged 7 to 17 years, including effective management of adverse effects. In addition, it will provide learners with a structured framework to support safe and effective transition of adolescents with IBS-C to adult care, emphasizing readiness assessment, care coordination, and continuity of medication therapy to optimize long-term patient outcomes.

In this online, self-learning activity:

Human immunodeficiency virus (HIV) is a retrovirus that preferentially targets CD4+ T lymphocytes, driving chronic immune activation, CD4+ depletion, and heightened vulnerability of people living with it (PLWH) to opportunistic infections and certain malignancies. Early, guideline-concordant primary care engagement is essential to mitigate these risks and optimize long-term outcomes. Contemporary antiretroviral therapy (ART) recommendations from major panels provide multiple highly effective, well-tolerated options that enable durable viral suppression when initiated promptly and supported over time.

In this brief 15-minute activity, you will:

– Follow the case of a patient who presents with foot drop and no other medical conditions
– Choose optimal management approaches by answering nongraded questions within the activity (answers are collected for informational purposes only and used to assess the effectiveness of this educational activity)
– See how your answers compare with those of your peers
– View video clips providing expert insights

Pri-Med offers a diverse library of physician assistant CME/CE, providing clinically focused education for every stage of your career. Whether you’re a newly practicing physician assistant transitioning from the classroom to the exam room or an experienced clinician, you’ll find the resources you need to grow professionally.

The Primary Care Playbook for Obesity: Evidence, Engagement, and Effective Management is designed for primary care physicians, physician associates, and nurse practitioners involved in the care of patients with obesity in the United States. This activity addresses persistent gaps in the diagnosis and long-term management of obesity, including inconsistent application of evidence-based criteria and underutilization of effective therapies. Participants will build skills in accurate identification and documentation of obesity, as well as the use of structured, person-first communication to support patient engagement. The program also focuses on selecting individualized, evidence-based treatment plans and implementing longitudinal management strategies that incorporate counseling, pharmacotherapy, and shared decision-making.

Beyond Daily Injections: Implementing Once-Weekly Basal Insulin to Simplify and Personalize Care is designed for US-based endocrinologists and endocrinology-focused NPs and PAs involved in the management of patients with type 2 diabetes (T2D). Once-weekly basal insulin regimens are poised to enter the treatment armamentarium for diabetes management. Gaps in understanding the unique molecular design and pharmacology of, and latest clinical data on these novel formulations may contribute to therapeutic inertia and delayed implementation of a more convenient, flexible, and potentially safer alternative to daily insulin regimens for patients with T2D.

This interactive Real Answers to Real Questions CME activity will integrate extensive peer-to-peer discussion into didactive presentation elements and provide clinicians with the opportunity to examine the recent scientific advancements related to once-weekly basal insulins and compare their pro and cons with traditional once-daily basal insulin regimens. By tackling real-world, practical questions that endocrinologists and endocrinology-focused NPs and PAs face every day, the activity will prepare these clinicians to confidently integrate once-weekly basal insulins into patient-centered diabetes care when they become available.

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a demyelinating, autoimmune condition affecting the central nervous system. MOGAD is characterized by the presence of autoantibodies directed against the MOG protein located on the surface of myelin sheaths surrounding nerve fibers in the CNS. The disease course may be monophasic or relapsing, and a progressive course is extremely rare, making the mortality rate fairly low (2.1%) compared to other neuroinflammatory diseases. It is a relatively new addition to the category of demyelinating diseases, and approximately 10,000 cases of MOGAD are estimated within the U.S.

Explore Pri-Med’s comprehensive library of nurse practitioner CME/CE courses, designed to support clinicians at every stage of their career. Whether you’re a new nurse practitioner transitioning from training to practice or an experienced clinician seeking to deepen your expertise, Pri-Med offers a diverse range of clinically focused courses tailored to your needs. Enhance patient care and earn CME/CE credits with engaging, high-quality education—start today.